Regulatory Compliance
CenterWatch | Insights
Unpacking the FDA’s Guidance on Developing Drugs for Treatment in Pediatric Inflammatory Bowel Disease
Blog Posts
CenterWatch | Insights
Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications Guidance for Industry, IRBs, and Clinical Investigators
Blog Posts
CenterWatch | Insights
Cancer Clinical Trial Eligibility Criteria: Performance Status Guidance for Industry, IRB, and Clinical Investigators
Blog Posts
CenterWatch | Insights
Demystifying FDA Processes: Why Do Changes in Regulations Take so Long?
Blog Posts
CenterWatch | Insights
Review of Emergency Research
Whitepapers
CenterWatch | Insights
FDA Guidance and Revised OMB Guidance on the Collection of Race and Ethnicity Data
Blog Posts
CenterWatch | Insights
Ask the Experts: What Is E-consent? What Are E-signatures?
Blog Posts
CenterWatch | Insights
Sunsetting FDA Enforcement Discretion of Laboratory Developed Tests
Blog Posts
CenterWatch | Insights
How WCG Is Preparing for FDA Harmonization with the Common Rule
Blog Posts
CenterWatch | Insights